Steve Felstead
Directeur/Membre du Conseil chez MGB Biopharma Ltd.
Profil
Steve Felstead is a Non-Executive Director at MGB Biopharma Ltd.
He was also a Non-Executive Director at Photopharmica Ltd.
and served as Vice President at Pfizer Ltd.
from 2009 to 2014.
Additionally, he worked as the Chief Medical Officer at Destiny Pharma Plc.
Postes actifs de Steve Felstead
| Sociétés | Poste | Début |
|---|---|---|
MGB Biopharma Ltd.
 MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Directeur/Membre du Conseil | - |
Anciens postes connus de Steve Felstead
| Sociétés | Poste | Fin |
|---|---|---|
| DESTINY PHARMA PLC | Directeur Technique/Scientifique/R&D | 26/09/2018 |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Corporate Officer/Principal | 01/01/2014 |
Photopharmica Ltd.
 Photopharmica Ltd. Medical SpecialtiesHealth Technology Photopharmica Ltd. develops and discovers novel photosensitizer products. Its products pipeline includes phenothiazinium photosensitizers for use as topical therapeutic antimicrobial agents and phthalocyanine photo sensitizers that combine anti-tumor properties with minimal or zero skin photo sensitization. The firm's light-activated drugs kill common disease-causing microorganisms including Gram positive and negative bacteria. The company was founded in 2001 by John Lyon and is headquartered in Leeds, the United Kingdom. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DESTINY PHARMA PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Photopharmica Ltd.
Photopharmica Ltd. Medical SpecialtiesHealth Technology Photopharmica Ltd. develops and discovers novel photosensitizer products. Its products pipeline includes phenothiazinium photosensitizers for use as topical therapeutic antimicrobial agents and phthalocyanine photo sensitizers that combine anti-tumor properties with minimal or zero skin photo sensitization. The firm's light-activated drugs kill common disease-causing microorganisms including Gram positive and negative bacteria. The company was founded in 2001 by John Lyon and is headquartered in Leeds, the United Kingdom. | Health Technology |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Health Technology |
MGB Biopharma Ltd.
MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Health Technology |